The Global CRISPR Gene Editing Market is projected to grow at a CAGR of around 18.24% during the forecast period, 2022-27.                                                               

Global CRISPR Gene Editing Market Dynamics:

Key Driver: Prevalence of Genetic Disorders & Use of Genome Editing to Boost the Market Growth

The prevalence of genetic disorders has been increasing over the years across the globe. Some of the most prevalent are thalassemia, down syndrome, cystic fibrosis, and sickle cell anemia. For every 10,000 live births globally, 4.4 cases of thalassemia are reported. According to the Thalassemia International Federation, about 7% of the population experience hemoglobin-associated conditions, around 70% have sickle cell anemia, and the remaining develop thalassemia or other blood disorders.

Further, in recent years, CRISPR gene editing demand has been driven by significant breakthrough scientific research across various dimensions to treat hereditary disorders. As per the research publication of the New England Journal of Medicine, 2020, CRISPR gene therapies depicted positive results for treating sickle cell anemia & beta-thalassemia. In addition, ongoing clinical trials for the gene correction in homo sapiens to treat genetic disorders further augmented the growth of the CRISPR Gene Editing market globally. For instance:

·       Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease (CEDAR) clinical trial was posted in the USA, as of 2021, which is considered a first-in-human, single-arm study. The study is currently in Phase1/11 & is expected to be completed in 2026.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/crispr-gene-editing-market.html

Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report. 

Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/crispr-gene-editing-market.html

Global CRISPR Gene Editing Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2021

-Historical Period: 2017 to 2020

-Forecast Period: 2022-27

• By Product Type
• CRISPR Products
• Kits & Enzymes
• Libraries
• Design Tools
• Antibodies
• Others
• CRISPR Services
• gRNA Design & Vector Construction
• Cell Line and Engineering
• Screening Services
• Others
• By Application
• Agriculture
• Industrial
• Biomedical
• Gene Therapy
• Drug Discovery
• Diagnostics
• Others
• By End User
• Academic Institutions and Research Centers
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Pharmaceutical & Biopharmaceutical Companies
• By Region
• North America
• South America
• Europe
• Middle East & Africa
• Asia Pacific

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including -   Abcam Inc., Applied StemCell Inc., Agilent Technologies Inc., Cellecta Inc., CRISPR Therapeutics AG, Thermo Fischer Scientific Inc., GeneCopoeia Inc., GeneScript Biotech Corporation, Horizon Discovery Group PLC, Integrated DNA Technologies Inc., Merck KGaA, New England Biolabs, Inc., Origene Technologies Inc., Rockland Immunochemicals Inc., Others (Synthego Corporation, ToolGen Inc., etc.)

Get Instant Access to Exclusive Market Data – Choose Your License as per Your Business Needs & Avail Special Offer – Buy Now - https://www.marknteladvisors.com/pricing/crispr-gene-editing-market.html

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release